Egill Másson

Egill has 16 years of experience in the medical device industry and has been on the board of directors of 15 startups.

He was CEO of the EEG company Taugagreining, which was acquired by Natus Medical.

Later, Egill was an investment manager at NSA Ventures, an Icelandic seed and early-stage venture fund with a focus on software and medical devices. Egill sits on the investment advisory board of Crowberry Capital, a private Icelandic VC fund focusing on early startups.

Egill has a B.Sc. in computer science and physics and an M.Sc. in computer science from the University of Copenhagen.